159 related articles for article (PubMed ID: 25873358)
1. Association between positive murine double minute 2 expression and clinicopathological characteristics of esophageal squamous cell carcinoma: a meta-analysis.
Chen JY; Yang H; Wen J; Luo KJ; Liu QW; Lei JY; Zhen YZ; Fu JH
Dis Esophagus; 2016 Oct; 29(7):856-863. PubMed ID: 25873358
[TBL] [Abstract][Full Text] [Related]
2. The expression of murine double minute 2 is a favorable prognostic marker in esophageal squamous cell carcinoma without p53 protein accumulation.
Saito H; Tsujitani S; Oka S; Ikeguchi M; Maeta M; Kaibara N
Ann Surg Oncol; 2002 Jun; 9(5):450-6. PubMed ID: 12052755
[TBL] [Abstract][Full Text] [Related]
3. Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy.
Okamoto H; Fujishima F; Kamei T; Nakamura Y; Ozawa Y; Miyata G; Nakano T; Katsura K; Abe S; Taniyama Y; Sakurai T; Teshima J; Hikage M; Sasano H; Ohuchi N
BMC Cancer; 2015 Mar; 15():208. PubMed ID: 25880782
[TBL] [Abstract][Full Text] [Related]
4. Association of p53 and MDM2 polymorphisms with risk of human papillomavirus (HPV)-related esophageal squamous cell carcinoma (ESCC).
Yang J; Liu B; Li W; Xiong H; Qiu H; Fu Q; Chen B; Hu G; Yuan X
Cancer Epidemiol; 2013 Oct; 37(5):629-33. PubMed ID: 23837945
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY
BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of PLCE1 in Kazakh esophageal squamous cell carcinoma: implications in cancer metastasis and aggressiveness.
Chen YZ; Cui XB; Hu JM; Zhang WJ; Li SG; Yang L; Shen XH; Liu CX; Pan QF; Yu SY; Yuan XL; Yang L; Gu WY; Chen JZ; Wang LD; Li F
APMIS; 2013 Oct; 121(10):908-18. PubMed ID: 23659763
[TBL] [Abstract][Full Text] [Related]
7. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between hypoxia inducible factor-1α and esophageal squamous cell carcinoma: a meta analysis].
Jing S; Wang J; Liu Q; Cheng Y; Yang C; Wang Y; Cao F; Wen B; Jiao W; Guo Y
Zhonghua Bing Li Xue Za Zhi; 2014 Sep; 43(9):593-9. PubMed ID: 25471499
[TBL] [Abstract][Full Text] [Related]
9. Genetic Variants in the p14ARF/MDM2/TP53 Pathway Are Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated with Radical Resection.
Li J; Tang Y; Huang L; Yu Q; Hu G; Yuan X
PLoS One; 2016; 11(7):e0158613. PubMed ID: 27414035
[TBL] [Abstract][Full Text] [Related]
10. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma.
Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y
Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of PLCE1 expression in upper gastrointestinal cancer: a systematic review and meta-analysis.
Cui XB; Peng H; Li S; Li TT; Liu CX; Zhang SM; Jin TT; Hu JM; Jiang JF; Liang WH; Li N; Li L; Chen YZ; Li F
Asian Pac J Cancer Prev; 2014; 15(22):9661-6. PubMed ID: 25520085
[TBL] [Abstract][Full Text] [Related]
13. Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53.
Chen Y; Xin H; Peng H; Shi Q; Li M; Yu J; Tian Y; Han X; Chen X; Zheng Y; Li J; Yang Z; Yang L; Hu J; Huang X; Liu Z; Huang X; Zhou H; Cui X; Li F
Cancer Res; 2020 Jun; 80(11):2175-2189. PubMed ID: 32066565
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
[TBL] [Abstract][Full Text] [Related]
15. p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma.
Taghavi N; Biramijamal F; Sotoudeh M; Khademi H; Malekzadeh R; Moaven O; Memar B; A'rabi A; Abbaszadegan MR
BMC Cancer; 2010 Apr; 10():138. PubMed ID: 20388212
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of c-MYC in esophageal squamous cell carcinoma.
Lian Y; Niu X; Cai H; Yang X; Ma H; Ma S; Zhang Y; Chen Y
Tumour Biol; 2017 Jul; 39(7):1010428317715804. PubMed ID: 28671049
[TBL] [Abstract][Full Text] [Related]
17. MDM2 is overexpressed and regulated by the eukaryotic translation initiation factor 4E (eIF4E) in human squamous cell carcinoma of esophagus.
Hsu HS; Chen HW; Kao CL; Wu ML; Li AF; Cheng TH
Ann Surg Oncol; 2011 May; 18(5):1469-77. PubMed ID: 21080085
[TBL] [Abstract][Full Text] [Related]
18. Association between SNP309 and del1518 Polymorphism in MDM2 Homologue and Esophageal Squamous Cell Carcinoma Risk in Chinese Population of Shandong Province.
Zhang L; Zhu Z; Wu H; Wang K
Ann Clin Lab Sci; 2015; 45(4):433-7. PubMed ID: 26275695
[TBL] [Abstract][Full Text] [Related]
19. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
[TBL] [Abstract][Full Text] [Related]
20. The high expression instead of mutation of p53 is predictive of overall survival in patients with esophageal squamous-cell carcinoma: a meta-analysis.
Zhao Z; Wang P; Gao Y; He J
Cancer Med; 2017 Jan; 6(1):54-66. PubMed ID: 27882726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
